Electromed, Inc. (ELMD) is a publicly traded Healthcare sector company. As of May 21, 2026, ELMD trades at $37.74 with a market cap of $316.63M and a P/E ratio of 31.26. ELMD moved -1.54% today. Year to date, ELMD is +33.64%; over the trailing twelve months it is +69.85%. Its 52-week range spans $17.73 to $39.25. Analyst consensus is strong buy with an average price target of $38.00. Rallies surfaces ELMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Electromed Posts 16.3% Revenue Growth to $18.9M and 42% Operating Income Rise: Electromed reported record FQ2 2026 net revenues of $18.9 million, up 16.3% year-over-year, with core home care sales rising 18.4% to $17.3 million. Operating income jumped 42.4% to $3.6 million and net income reached $2.8 million, resulting in earnings per share of $0.32.
| Metric | Value |
|---|---|
| Price | $37.74 |
| Market Cap | $316.63M |
| P/E Ratio | 31.26 |
| EPS | $1.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.25 |
| 52-Week Low | $17.73 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $71.75M |
| Net Income | $10.10M |
| Gross Margin | 78.44% |
3 analysts cover ELMD: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.00.